NOD Pharmaceuticals, Ltd., Shanghai, China

NOD Pharmaceuticals, with headquarters in Shanghai, is an emerging global leader in the oral delivery of protein/peptide drugs. It has developed “NOD” or nano-particle oral delivery as a platform technology to develop multiple products each with blockbuster potential. The market value of the products that are suitable for the NOD technology exceeds US$30 billion at present and is projected to exceed US$100 billion by year 2010.